Novel Drug Delivery System Market by Route (Oral Drug Delivery Systems, Pulmonary Drug Delivery Systems, Injectable Drug Delivery Systems, Transdermal Drug Delivery Systems, Others); by Mode (Targeted Drug Delivery Systems, Modulated Drug Delivery Systems, Controlled Drug Delivery Systems); by Region (North America, Europe, Asia-Pacific, LAMEA): Global Forecasts 2017 To 2027

The Global Novel Drug Delivery System Market Size was valued at USD 54.5 Bn in 2020 is expected to reach USD 86.5 Bn by 2027, with a growing CAGR of 7.1 % during the forecast period.

Novel drug delivery system is defined as innovative approaches, technologies, formulations, and system of transporting active pharmaceutical ingredients into the body to achieve the desired pharmacological effect. NDDS involve various types of formulations like nanoparticles, liposomes, nanoemulsion, nanogel, and microemulsion etc. NDDS paves the way for formulating more precise and targeted drug delivery.

Advantages of NDDS include dose optimization, less side effect, targeted drug delivery and cost-effective production. NDDS helps to increase the drug efficiency. NDDS are formulated to reduce side-effects, increase drug stability and bioavailability.

Novel Drug Delivery Market Size

The driving factors for global novel drug delivery system include increase in the adoption of innovative drug delivery methods, rise in demand for targeted drug delivery systems, increase in government funding for research & development facilities. Further advances in formulation procedures and promotion of NDDS promote the growth of novel drug delivery system market. Moreover, adoption of controlled release drug delivery system and aim to provide better therapy to patients thrives the growth of novel drug delivery system market.

The adoption of a controlled release drug delivery system has gained huge importance in the last decades due to development in formulation and production procedures. In addition to this, the target of providing right dose at right place boost the growth of novel drug delivery system market. The growth of novel drug delivery system market is expected to expand more during the forecast period.

Novel Drug Delivery System Market Segmentation:

By Route

  • Oral Drug Delivery Systems
  •  Pulmonary Drug Delivery Systems
  •  Injectable Drug Delivery Systems
  •  Transdermal Drug Delivery Systems
  •  Others

By Mode

  • Targeted Drug Delivery Systems
  •  Modulated Drug Delivery Systems
  •  Controlled Drug Delivery Systems

By Region

  • North America
  •  Europe
  •  Asia-Pacific
  •  Rest of the World

Based on route, oral drug delivery system accounted for the highest market share in 2020 and expected to increase more during forecast period owing to most adoptable and convenient route of drug administration

Based on route, novel drug delivery system market is broadly segmented into oral drug delivery systems, pulmonary drug delivery systems, injectable drug delivery systems and transdermal drug delivery systems. Oral drug delivery is expected to hold highest market share during forecast period due to high patient compliance. Oral route is most common and widely used route of drug administration. Oral drug delivery offers set of advantages over other routes such as easy to administer, cost-effective, easy to store, ease of production and flexibility in the design of formulation which creates opportunity of growth of novel drug delivery system market.

Oral route of drug administration is the successful route for controlled drug release formulations. However, immediate release formulation lack in efficiency of controlling plasma concentration. Oral drug delivery system is majorly driven by rising chronic diseases, patient centric approaches, growing investments by government & private companies in production and repositioning drug molecule using innovative oral drug formulations.

Based on mode, controlled drug delivery system is expected to hold maximum market share during forecast period due to increase in demand for controlled release formulation

Based on mode, novel drug delivery system market is segmented into targeted drug delivery systems, modulated drug delivery systems and controlled drug delivery systems. Controlled drug delivery system has gained huge popularity in drug delivery systems owing to the most acceptable drug formulation. Controlled drug delivery system offers controlled release of drug from formulation and lessen drug toxicity that boost the growth of novel drug delivery system market. It helps to maximize efficacy and minimize side effects. Factors such as less dosing frequency, improved patient acceptance & compliance drives the growth of novel drug delivery system market.

However, targeted drug delivery anticipates the fastest growth with highest CAGR during forecast period owing to increase in research related to targeted therapy and a rise in demand for fast site action. Moreover, increase in chronic diseases such as cancer, diabetes creates the need for a targeted drug delivery system.

Based on geographical region, North America accounted for highest market share in 2020 and expected to maintain it’s dominance during the forecast period due to increase in chronic diseases and rise in health care expenditure

Geographically, North America is expected to hold largest market share during forecast period due to rising healthcare infrastructure and ever-increasing chronic diseases. According to American Heart Association, 2018 report, approximately 2.84 million people in U.S lost their lives due to heart diseases and cancer accounting for a combined 45% of all deaths. Cancer & heart attack are the most common and unpleasant ways of death in America. This led to increase in number of pharmaceutical industries and manufacturing unit in this region which ultimately tend to increase growth of novel drug delivery system market. Other factors such as strong government support, increase in R&D facilities, rise in novel drug discovery and growing awareness regarding availability of various drug delivery system thrives the growth of novel drug delivery system market in North America.

Company Profiles and Competitive Intelligence

The key players operating in the novel drug delivery system market are:

  • Abbott Laboratories
  • AstraZeneca PLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Tolmar
  • Astellas
  • Aspen
  • Breckenridge Pharmaceuticals
  • Shire
  • Galen
  • 3M Company
  • Teva Pharmaceuticals Industries Limited
  • Boston Scientific
  • Genzyme Co.
  • Lupin
  • Boehringer Ingelheim

The report also provides in-depth analysis of novel drug delivery system market dynamics such as drivers, restraints opportunities and challenges

Drivers

  • Rise in government spending in R&D
  • Increase in product approvals and launches
  • Increase in demand for controlled drug release system
  • Increase in technological advances in healthcare
  • Rise in demand for self-administration medication

Restraints

  • Rising cost associated with advanced healthcare procedures hampers the growth of novel drug delivery system market
  • Lack of awareness of NDDS in developing countries
  • Stringent government policies for product approvals

Opportunities

  • Rise in nanotechnology-based drug delivery systems provides opportunities for players in the novel drug delivery system market.
  • Frequent innovation in novel drug delivery systems creates an opportunity for portfolio expansion

Challenges

  • Increase in cost of treatment and medication
  • Increase in product and product recalls is the major challenge in the growth of gobal novel drug delivery system

COVID-19 Impact on the Novel Drug Delivery System Market Analysis

Covid-19 has highly affected the industries in terms of growth, economy, health, and mental wellbeing of every individual. In this challenging situation, every industry is trying to give best services in terms of quality and safety. Novel drug delivery system manufacturers and researchers are leveraging the covid-19 pandemic with clinical & pre-clinical trials for vaccine delivery systems which is expected to boost the growth of novel drug delivery system market in coming years.

Coronavirus outbreak has created sudden influx of patients, which has generated huge demand for the drug delivery system. This is creating opportunity for the players to expand their production capacities for the foreseeable.

The report also provides in-depth analysis of key trends in novel drug delivery system market

  • Sudden increase in demand for drug delivery system during covid-19 outbreak have triggered the growth of novel drug delivery system market
  • Increase in government initiatives, development in innovative techniques and demand for controlled & targeted drug release system drives the growth of novel drug delivery system market.

The report also provides in-depth analysis of recent news developments and investments

  • In August 2021, Bayer acquired Vividion Therapeutics at $1.5 Bn to strengthen their portfolio from small molecules to new modalities for novel drug discovery platform.
  • In July 2019, Lupin aims to launch its first biosimilar product in the U.S. And across the globe to maintain sustainable growth and to expand its injectable portfolio.

The unique insights provided by this report also includes the following:

  • In-depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-benchmarking Heat Map
  • Market Trends
  • Covid-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impacts on Novel Drug Delivery System market
  • Competitive Landscape

Frequently Asked Questions (FAQs)

The global novel drug delivery system market was valued at USD 54.5 Bn in 2020 and is anticipated to reach USD 86.5 Bn by 2027

The novel drug delivery system market is estimated to grow at a compound annual growth rate (CAGR) of 7.1 % during 2021-2027

In the base year 2020, North America accounted for 43% share in the novel drug delivery system market

High treatment cost and high product recall rate restraint the growth of global novel drug delivery system market.

As per expert opinion, increase in product launch and surge for self-administration of medication will drive the growth of global novel drug delivery system market.

Few key players include, but not limit up to: Abbott Laboratories, AstraZeneca PLC, Bayer AG, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc. and Sanofi SA

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1.  Introduction
    1. Product Outline
    2. What is Novel Drug Delivery System
    3. Analysis of Novel Drug Delivery System
    4. Covid -19 Impact
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
    6. Technology Overview
  2. Regulatory Landscape for Novel Drug Delivery System
    1. Regulations and Standards
  3. Novel Drug Delivery System Market by Route
    1. Oral Drug Delivery Systems
    2. Pulmonary Drug Delivery Systems
    3.  Injectable Drug Delivery Systems
    4.  Transdermal Drug Delivery Systems
    5.  Others
  4. Novel Drug Delivery System Market by Mode
    1. Targeted Drug Delivery Systems
    2.  Modulated Drug Delivery Systems
    3.  Controlled Drug Delivery Systems
  5. Regional Analysis
    1. North America
      1. US
      2. Canada
    2. Europe
      1. Germany
      2. UK
      3. France 
      4. Spain
      5. Netherlands
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest Of Asia Pacific
    4. LAMEA
  6. Key Strategic Insights
  7. Market Analysis
    1. New Applications
    2. Emerging Technologies
    3. Opportunity Mapping
    4. Critical Success Factors
    5. Consumer Preferences
  8. Key Market Trends / Recent Developments
  9. Competitive Scenario
    1. Mergers and Acquisitions
    2. Investments
    3. Joint Ventures
    4. New Product Launches
    5. Ranking of Key Players
    6. Presence of Players by Geographies
  10. Key global players
    1. Abbott Laboratories
    2. AstraZeneca PLC
    3. Bayer AG
    4. F. Hoffmann-La Roche AG
    5.  GlaxoSmithKline PLC
    6.  Johnson & Johnson
    7. Merck & Co., Inc.
    8.  Novartis AG
    9.  Pfizer Inc.
    10. Sanofi SA
    11. Tolmar
    12. Astellas
    13. Aspen
    14. Breckenridge Pharmaceuticals
    15. Shire
    16. Galen

Choose License

License Type
Ask for Customization

Why Choose AllTheResearch?

  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on Quadrant Positioning of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports.Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.
Speak to Analyst

Quick Inquiry

Follow Us

Choose License

License Type
Ask for Customization